Xihong Biopharma participated in the Istanbul Beauty Expo 2026, presenting its full range of aesthetic injectable products and strengthening its global positioning in the medical aesthetics and regenerative medicine market.
Xihong Biopharma highlighted a complete aesthetic injectable portfolio strategy, offering a full solution system for clinics, distributors, and OEM partners worldwide.
At the exhibition, Xihong Biopharma showcased a comprehensive product line covering key segments of the global aesthetic industry, including:
This diversified portfolio enables treatment protocols across facial volume restoration, collagen stimulation, skin regeneration, hydration improvement, and long-term anti-aging solutions.
During the exhibition, Xihong Biopharma booth attracted significant attention from dermatology clinics, aesthetic physicians, distributors, and OEM/private label partners from Europe, the Middle East, and Asia.
Among all product categories, PDRN skin regeneration products and NCTF mesotherapy solutions received particularly strong interest due to their increasing use in skin rejuvenation, hydration enhancement, and anti-aging treatment protocols.
Xihong Biopharma also highlighted its OEM and private label manufacturing services, supporting global partners in building customized aesthetic brands.
Services include:
This allows partners to rapidly enter the growing aesthetic medicine market with scalable product solutions.
Xihong Biopharma noted that the global aesthetic industry is rapidly shifting toward combination therapy and full-face treatment planning, where clinics increasingly prefer suppliers offering multi-category injectable solutions rather than single-product sourcing.
This trend is driving demand for integrated product ecosystems that combine biostimulators, fillers, and skin boosters within one treatment strategy.
By presenting a full aesthetic injectable portfolio at Istanbul Beauty Expo 2026, Xihong Biopharma further strengthened its international brand visibility and expanded cooperation opportunities with global partners.
The company will continue to invest in innovation and global market development across key product lines including PLLA, CaHA, PDRN, NCTF, Skinbooster, and PMMA, delivering safe, effective, and science-driven aesthetic solutions worldwide.
